These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11693849)

  • 41. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer].
    Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC
    Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Facemasks and facial deposition of aerosols.
    Sangwan S; Gurses BK; Smaldone GC
    Pediatr Pulmonol; 2004 May; 37(5):447-52. PubMed ID: 15095329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of beclomethasone dipropionate aerosolized through different nebulizers to asthmatic patients.
    Terzano C; Guerra S; Allegra L
    Eur Rev Med Pharmacol Sci; 2001; 5(2):43-51. PubMed ID: 11863318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deposition of aerosols delivered by nasal route with jet and mesh nebulizers.
    Vecellio L; De Gersem R; Le Guellec S; Reychler G; Pitance L; Le Pennec D; Diot P; Chantrel G; Bonfils P; Jamar F
    Int J Pharm; 2011 Apr; 407(1-2):87-94. PubMed ID: 21256943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhaled tryptase causes bronchoconstriction in sheep via histamine release.
    Molinari JF; Scuri M; Moore WR; Clark J; Tanaka R; Abraham WM
    Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):649-53. PubMed ID: 8810600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different bronchoconstrictor effects of carbachol boluses inhaled near residual volume or total lung capacity.
    Gayrard P; Badier M; Vervloet D; Orehek J
    Respiration; 1987; 51(2):81-5. PubMed ID: 3589180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of realistic airflow rate on aerosol generation by nebulizers.
    Vecellio L; Kippax P; Rouquette S; Diot P
    Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between regional ventilation and aerosol deposition in tidal breathing.
    Trajan M; Logus JW; Enns EG; Man SF
    Am Rev Respir Dis; 1984 Jul; 130(1):64-70. PubMed ID: 6377999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calculating expected lung deposition of aerosolized administration of AAV vector in human clinical studies.
    Leung K; Louca E; Munson K; Dutzar B; Anklesaria P; Coates AL
    J Gene Med; 2007 Jan; 9(1):10-21. PubMed ID: 17154340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct isotopic assessment of aerosolized pentamidine deposition: influence of nebuliser.
    Diot P; Le Pape A; Becquemin MH; Besnier JM; Boissinot E; Bastides F; Benjemaa M; Choutet P; Lemarie E
    Eur J Med; 1993; 2(8):484-8. PubMed ID: 8258049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aerosol deposition in equine lungs following ultrasonic nebulisation versus jet aerosol delivery system.
    Votion D; Ghafir Y; Munsters K; Duvivier DH; Art T; Lekeux P
    Equine Vet J; 1997 Sep; 29(5):388-93. PubMed ID: 9306067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Airway responsiveness to inhaled and intravenous carbachol in sheep: effect of airway mucus.
    Kim CS; Eldridge MA; Wanner A
    J Appl Physiol (1985); 1988 Dec; 65(6):2744-51. PubMed ID: 3215874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Distribution of inhaled aerosol using nasal nebulizer].
    Ogoshi T; Usui N
    Nihon Jibiinkoka Gakkai Kaiho; 1991 Jan; 94(1):51-6. PubMed ID: 2019914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SPECT/CT study of bronchial deposition of inhaled particles. A human aerosol vaccination model against HPV.
    Ilic V; Dunet V; Le Pape A; Buchs M; Kosinski M; Bischof Delaloye A; Gerber S; Prior JO
    Nuklearmedizin; 2016 Sep; 55(5):203-8. PubMed ID: 27440125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization and deposition of respirable large- and small-particle bioaerosols.
    Thomas RJ; Webber D; Sellors W; Collinge A; Frost A; Stagg AJ; Bailey SC; Jayasekera PN; Taylor RR; Eley S; Titball RW
    Appl Environ Microbiol; 2008 Oct; 74(20):6437-43. PubMed ID: 18723664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional deposition of nebulized hypodense nonisotonic solutions in the human respiratory tract.
    Chan HK; Phipps PR; Gonda I; Cook P; Fulton R; Young I; Bautovich G
    Eur Respir J; 1994 Aug; 7(8):1483-9. PubMed ID: 7957834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Choosing a nebulizer for cystic fibrosis applications.
    Geller DE
    Curr Opin Pulm Med; 1997 Nov; 3(6):414-9. PubMed ID: 9391760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial characterization of micafungin pulmonary delivery via two different nebulizers and multivariate data analysis of aerosol mass distribution profiles.
    Shi S; Ashley ES; Alexander BD; Hickey AJ
    AAPS PharmSciTech; 2009; 10(1):129-37. PubMed ID: 19189220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs.
    Ben-Jebria A; Chen D; Eskew ML; Vanbever R; Langer R; Edwards DA
    Pharm Res; 1999 Apr; 16(4):555-61. PubMed ID: 10227712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of jet and ultrasonic nebulizers for alveolar targeting of methylprednisolone.
    Véra P; Blot F; Gambini DJ; Becquemin MH; Dumas F; Beyne P; Caubarrere I; Barritault L
    Nucl Med Commun; 1995 May; 16(5):344-8. PubMed ID: 7659386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.